1 / 17

State Responses to Medicare Part D

State Responses to Medicare Part D. Presented by: Kimberley Fox, Senior Policy Analyst, Institute for Health Policy Academy Health Annual Research Meeting Seattle, WA June 2006. Survey Methods. Funded by the National Pharmaceutical Council Literature and document review

forest
Télécharger la présentation

State Responses to Medicare Part D

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. State Responses to Medicare Part D Presented by: Kimberley Fox, Senior Policy Analyst, Institute for Health Policy Academy Health Annual Research Meeting Seattle, WA June 2006

  2. Survey Methods • Funded by the National Pharmaceutical Council • Literature and document review • Fall 2005 survey w/ telephone follow-up • Snapshot of states’ plans for adapting programs to MMA • 24 existing SPAP programs • 14 Medicaid agencies (representing 66% of Medicaid drug spend), 11 in states with SPAPs. • Response rate: @96% • Findings reflect responses at time of survey completion. Muskie School of Public Service

  3. State Responsibilities/Options Under Part D Medicaid • Assist w/ transitioning duals • Clawback payments • LIS application and MSP screening responsibilities. • May fill Part D gaps with state-only dollars State Pharmacy Assistance Programs (SPAP) • May fill Part D gaps • Qualified SPAP expenditures count toward TROOP • Part D plans must coordinate • Transitional grant funding available Muskie School of Public Service

  4. Key Differences between Part D and State Pharmacy Coverage Medicaid • May face higher copayments • Loss of guaranteed access if they can’t afford copayments • No coverage of excluded drugs under Part D • Formularies may not include drugs covered under Medicaid • Loss of coverage of denied drugs during appeal • More limited pharmacy networks. State Pharmacy Assistance Programs (SPAPs) • Tighter formularies/ more limited pharmacy networks • LIS eligible – potentially lower cost-sharing • Non-LIS eligible – • Up-front costs such as premiums and deductibles previously not required in many programs • Higher cost-sharing before and in the donut hole (varies by state). Muskie School of Public Service

  5. Part D Transitional Enrollment Issues for SPAP Enrollees and Duals • Duals • Medicaid drug coverage ends Jan 2006 • All duals ‘deemed eligible’ for low income subsidies • Randomly assigned to below benchmark PDPs by CMS – Nov 2005 • State Medicaid agencies can conduct formulary matches to recommend more appropriate plans. • SPAP Enrollees • Most not deemed eligible for LIS, must apply (exc. MSPs) • All enrollees must voluntarily enroll in PDP/MA-PD • Qualified SPAPs cannot auto-enroll enrollees into a preferred plan • Various options to ‘facilitate’ LIS application/Part D enrollment Muskie School of Public Service

  6. SPAP and Medicaid Part D Gap-filling Options • Medicaid • Premium assistance above LIS benchmark • Copayments • Off-formulary/PDP denied drugs or during appeals • Non-Part D covered drugs (eligible for FFP) • SPAP • Premium assistance (LIS or full premium) • Wrap around full/partial LIS or non-LIS out-of-pocket costs • Deductibles, copayments, donut hole, • Off-formulary/PDP denied drugs or out-of-network pharmacies • Non-Part D covered drugs Muskie School of Public Service

  7. Filling Part D Gaps for Duals: Selected Medicaid Plans 2006 NY NY NJ NJ NY,NJ NY,NJ NJ NJ Source: Part D Survey of SPAP and Medicaid Directors, Fall 2005. Muskie School of Public Service

  8. Medicaid Transition Plans for Part D Enrollment, 2005 Source: Part D Survey of SPAP and Medicaid Directors, Fall 2005. Muskie School of Public Service

  9. SPAP Plans Once Part D Begins, 2006 Muskie School of Public Service

  10. Specific Part D Gaps Filled by SPAPs, 2006 Source: Part D Survey of SPAP and Medicaid Directors, Fall 2005. Muskie School of Public Service

  11. More than Half of SPAP Enrollees Will Not Qualify for Full LIS*N=26 programs/23 states *Percentages based on estimates by state officials from income data, generally do not include assets. Source: Part D Survey of SPAP and Medicaid Directors, Fall 2005. Muskie School of Public Service

  12. SPAP Efforts to Enroll Members in LIS, 2005 N=17 *For LIS and/or Part D Enrollment Source: Part D Survey of SPAP and Medicaid Directors, Fall 2005. Muskie School of Public Service

  13. SPAP Efforts to Enroll Members in Part D Plans, 2005 N=17 *For LIS and/or Part D Enrollment Source: Part D Survey of SPAP and Medicaid Directors, Fall 2005. Muskie School of Public Service

  14. Few States Expanding SPAPs to New Groups Source: Part D Survey of SPAP and Medicaid Directors, Fall 2005. Muskie School of Public Service

  15. Summary of State Actions • Short-term emergency coverage (Medicaid/ some SPAPs) • Medicaid largely not filling Part D gaps for duals over time, except Part D excluded drugs. • SPAPs holding existing enrollees harmless, but not expanding benefits/eligibility • Only a few states starting new SPAPs • States generally exercising caution… wait and see approach. Muskie School of Public Service

  16. Policy Implications/ Discussion • Differences in State D-Gap plans for duals and SPAP enrollees • Larger cost-sharing differences for non-LIS SPAP enrollees relative to prior coverage than for duals. • Large potential savings to SPAP as secondary payer; little savings and potential short-term losses from the clawback for Medicaid. • Formularies – to wrap or not to wrap. • Don’t want to encourage Part D plans to limit formularies to narrowest possible standard • Adverse effects from reduced drug coverage as a result of restricted formularies may result in more cost to the state if that leads to use of more expensive medical services. • States may want to reserve the right to cover in limited circumstances where likelihood of adverse events is higher. At minimum, could help duals appeal. • Reconsideration of federal match (?) • SPAPs Can Do More to Maximize SPAP Savings allowing them to potentially fill more gaps or expand eligibility. • Monitor state coverage decisions on duals and SPAP enrollees. Muskie School of Public Service

  17. Further Information • For copies of this presentation: • kfox@usm.maine.edu • Full report of survey findings available at: http://muskie.usm.maine.edu/m_view_publication.jsp?id=3409 Muskie School of Public Service

More Related